| Literature DB >> 29502107 |
Jingjing Zheng1, Da Zheng1, Terry Su1, Jianding Cheng2.
Abstract
Entities:
Keywords: arrhythmia; sudden cardiac death; sudden death; sudden unexplained nocturnal death syndrome
Mesh:
Substances:
Year: 2018 PMID: 29502107 PMCID: PMC5866328 DOI: 10.1161/JAHA.117.007837
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Milestones in SUNDS. It has been 100 years since the first description of SUNDS in 1917 in Philippines. There were 2 major active periods of studies on SUNDS: The early stage mainly focused on collecting the epidemiological characteristics and revealing the probable external environmental risk factors; the later stage was aimed at uncovering the intrinsic gene susceptibility. BrS indicates Brugada Syndrome; CCS, cardiac conduction system; CDC, Centers for Disease Control and Prevention; SUNDS, sudden unexplained nocturnal death syndrome; US, the United States; VF, ventricular fibrillation.
Epidemiology of SUNDS in Different Countries
| Country | Ethnicity | Inclusion Criteria | SUNDS Cases | Inci. | Mean Age | Peak Risk Age (y) | Sex Ratio | Peak Risk Month | Occupation | Symptoms Before Death | Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|
| USA (1981) | South‐East Asian refugees in the USA |
25–63 y old | 25 | 59–92 | 33 | NA | NA | NA | NA | Choking, gurgling, gasping, or labored respirations, without wheezing or stridor |
|
| USA (1987) | 5 | 1 | 33 | NA | 5/0 | NA | NA | NA |
| ||
| Singapore (1982–1990) | Thai workers in Singapore |
21–54 y old | 161 | 78 | 34 | NA | 161/0 | No mo pattern | Construction worker | Noisy breathing, gasping, or groaning |
|
| Thailand (1990) | Thai‐Lao in the northeast |
20–49 y old | 31 | 38 | 38 | 45–49 | 30/1 | Apr | Farmer or laborer | Groaning, muttering, choking or coughing, nightmare or night terror, restless sleep, spastic rigidity with or without contracting limbs, board‐like rigidity of abdominal wall, salivation, tongue biting |
|
| Philippines (1948–1982) | Filipinos in Manila |
25–44 y old | 772 | 10.8–26.3 | 33 | 30–34 | 24/1 | Dec–Jan | NA | NA |
|
| Philippines (2003) | Filipinos |
20–39 y old | 8 | 43 | 29.75 | NA | 3/1 | NA | NA | No moaning |
|
| China (2001–2013) | Han population of China |
15–55 y old | 1854 | 1 | 32 | 30 | 13.8/1 | Apr–Jun | Blue‐collar worker (97.7%) | Sudden tachypnea, strange groan or gasping, scream, abnormal snoring, sudden cough, abrupt tic of limbs, abrupt discomfort, white froth through mouth, feeling cold before retiring |
|
NA indicates not available; Ref, references; SCD, sudden cardiac death; SUNDS, sudden unexplained nocturnal death syndrome.
Inci: incidence: 1/100 000.
Sex ratio: male/female.
The year SUNDS cases were collected from.
Postmortem autopsies were negative: no lethal acute coronary thrombosis, myocardial infarction, or myocarditis accounting for death.
Figure 2Predicted protein topology of ion channels and the location of variations responsible for SUNDS. A, Cardiac sodium channel comprises a pore‐forming ion‐conducting α‐subunit Nav1.5 and ancillary β‐subunits. B through D, Predicted protein topology of Nav1.8 (SCN10A), Kv11.1 (KCNH2), Kv7.1 (KCNQ1), MinK (KCNE1), MiRP1 (KCNE2), CaV1.2 (CACNA1C), and RyR2. Pathogenicity is determined by ACMG guideline. ACMG indicates American College of Medical Genetics; SUNDS, sudden unexplained nocturnal death syndrome.
Spectrum of Genes Identified in SUNDS
| Gene | Locus | Protein | Current | Associated Disease |
|---|---|---|---|---|
| Na+ channels | ||||
| SCN5A | 3p22.2 | Sodium voltage‐gated channel α‐subunit 5 (Nav1.5) | INa | BrS |
| SCN1B | 19q13.11 | Sodium voltage‐gated channel β‐subunit 1 | INa | BrS |
| SCN3B | 11q24.1 | Sodium voltage‐gated channel β‐subunit 3 | INa | BrS |
| SCN10A | 3p22.2 | Sodium voltage‐gated channel α‐subunit 10 (Nav1.8) | INa | BrS |
| K+ channels | ||||
| KCNQ1 | 11p15.4‐15.5 | Potassium voltage‐gated channel subfamily Q member 1 (Kv7.1) | IKs | LQTS |
| KCNH2 | 7q36.1 | Potassium voltage‐gated channel subfamily H member 2 (Kv11.1) | IKr | LQTS |
| KCNE1 | 21q22.12 | Potassium voltage‐gated channel subfamily E regulatory subunit 1 (mink) | IKs | LQTS |
| KCNE2 | 21q22.11 | Potassium voltage‐gated channel subfamily E regulatory subunit 1 (MiRP1) | IKr | LQTS |
| KCNJ5 | 11q24.3 | Potassium voltage‐gated channel subfamily J member 5 (Kir3.4) | IKACh | LQTS |
| Ca2+ channels | ||||
| CACNA1C | 12p13.33 | Calcium voltage‐gated channel subunit α1 C (CaV1.2) | ICa,L | LQTS |
| CACNB2 | 10p12.31‐12.33 | Calcium voltage‐gated channel auxiliary subunit β‐2 | ICa,L | LQTS |
| RyR2 | 1q43 | Ryanodine receptor 2 | Ca2+ release | CPVT, ARVC |
| Connexome | ||||
| PKP2 | 12p11.21 | Plakophilin 2 | INa | ARVC |
| DSP | 6p24.3 | Desmoplakin | NA | ARVC |
| GJA1 | 6q22.31 | Gap junction protein α 1/Connexin 43 | NA | HLHS |
| VCL | 10q22.2 | Vinculin | INa | DCM, HCM |
| Other genes | ||||
| LRRC10 | 12q15 | Leucine‐rich repeat containing 10 | NA | DCM |
| ABCC9 | 12p12.1 | ATP binding cassette subfamily C member 9 | NA | AF |
| ACTN2 | 1q43 | α2‐Actinin | INa | DCM |
| AKAP9 | 7q21.2 | A‐kinase anchoring protein 9 | NA | LQTS |
| ANKRD | 10q23.31 | Ankyrin repeat domain | NA | DCM |
| DMPK | 19q13.32 | DM1 protein kinase | NA | LVNC |
| EYA4 | 6q23.2 | EYA transcriptional coactivator and phosphatase 4 | NA | DCM |
| GATA4 | 8p23.1 | GATA binding protein 4 | NA | AF |
| JUP | 17q21.2 | Junction plakoglobin | NA | ARVC |
| LDB3 | 10q23.2 | LIM domain‐binding protein 3 | NA | DCM, LVNC |
| LMNA | 1q22 | Lamin A/C | NA | DCM |
| MYBPC3 | 11p11.2 | Myosin‐binding protein C, cardiac‐type | NA | HCM, DCM, LVNC |
| MYH6 | 14q11.2 | Myosin 6 | NA | DCM, HCM |
| MYH7 | 14q11.2 | Myosin heavy chain 7 | NA | DCM, HCM, RCM |
| NUP155 | 5p13.2 | Nucleoporin 155 | NA | AF |
| SGCD | 5q33.2‐33.3 | Sarcoglycan delta | NA | DCM |
| TNNT2 | 1q32.1 | Troponin T2, cardiac type | NA | DCM |
AF indicates atrial fibrillation; ARVC, arrhythmogenic right ventricular cardiomyopathy; BrS, Brugada syndrome; CPVT, catecholaminergic polymorphic ventricular tachycardia; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; HLHS, hypoplastic left heart syndrome; LQTS, long QT syndrome; LVNC, left ventricular noncompaction; NA, not available; SUNDS, sudden unexplained nocturnal death syndrome.
Yields of Gene Variants in SUNDS Versus EAS in ExAC or gnomAD
| Gene | Alleles/Total SUNDS Cases (%) | ExAC | gnomAD | ||
|---|---|---|---|---|---|
| Alleles/Total EAS Exomes (%) |
| Alleles/Total EAS Exomes (%) |
| ||
| Na+ channels | |||||
| SCN5A | 13/167 (7.78) | 19/4327 (0.43) | <0.001 | 45/9345 (0.48) | <0.001 |
| SCN1B | 5/167 (2.99) | 63/4327 (1.46) | 0.214 | 144/9345 (1.53) | 0.249 |
| SCN3B | 1/167 (0.60) | 3/4327 (0.07) | 0.141 | 5/9345 (0.05) | 0.101 |
| SCN10A | 5/105 (4.76) | 152/4327 (3.51) | 0.696 | 338/9345 (3.58) | 0.736 |
| K+ channels | |||||
| KCNQ1 | 2/152 (1.32) | 5/4327 (0.12) | 0.022 | 17/9345 (0.18) | 0.037 |
| KCNH2 | 3/152 (1.97) | 6/4327 (0.14) | 0.003 | 15/9345 (0.16) | 0.003 |
| KCNE1 | 1/149 (0.67) | 0/4327 (0) | 0.034 | 0/9345 (0.00) | 0.016 |
| KCNE2 | 1/148 (0.68) | 0/4327 (0) | 0.034 | 0/9345 (0.00) | 0.016 |
| KCNJ5 | 1/44 (2.27) | 2/4327 (0.05) | 0.031 | 4/9345 (0.04) | 0.024 |
| Ca2+ channels | |||||
| CACNA1C | 2/44 (4.55) | 5/4327 (0.12) | 0.002 | 17/9345 (0.18) | 0.004 |
| CACNB2 | 1/44 (2.27) | 0/4327 (0) | 0.010 | 2/9345 (0.02) | 0.014 |
| Connexome | |||||
| PKP2 | 2/144 (1.39) | 0/4327 (0) | 0.001 | 0/9345 (0.00) | <0.001 |
| DSP | 5/40 (12.50) | 84/4327 (1.94) | 0.002 | 197/9345 (2.09) | 0.002 |
| GJA1 | 2/124 (1.61) | 0/4327 (0) | 0.001 | 0/9345 (0.00) | <0.001 |
| VCL | 1/44 (2.72) | 2/4327 (0.05) | 0.031 | 5/9345 (0.05) | 0.028 |
| Other genes | |||||
| LRRC10 | 3/113 (2.65) | 18/4327 (0.42) | 0.016 | 31/9345 (0.33) | 0.008 |
| ABCC9 | 1/44 (2.27) | 10/4327 (0.23) | 0.107 | 27/9345 (0.29) | 0.126 |
| ACTN2 | 2/44 (4.55) | 4/4327 (0.09) | 0.002 | 12/9345 (0.13) | 0.002 |
| AKAP9 | 2/44 (4.55) | 89/4327 (2.06) | 0.241 | 195/9345 (2.07) | 0.244 |
| ANKRD | 1/44 (2.27) | 11/4327 (0.25) | 0.117 | 22/9345 (0.23) | 0.104 |
| DMPK | 1/44 (2.27) | 0/4327 (0) | 0.01 | 9/9345 (0.10) | 0.047 |
| EYA4 | 1/44 (2.27) | 0/4327 (0) | 0.01 | 0/9345 (0.00) | 0.005 |
| GATA4 | 2/44 (4.55) | 0/4327 (0) | <0.001 | 0/9345 (0.00) | <0.001 |
| JUP | 1/44 (2.27) | 19/4327 (0.44) | 0.187 | 34/9345 (0.36) | 0.155 |
| LDB3 | 2/44 (4.55) | 10/4327 (0.23) | 0.007 | 26/9345 (0.28) | 0.008 |
| LMNA | 1/44 (2.27) | 0/4327 (0) | 0.01 | 3/9345 (0.03) | 0.019 |
| MYBPC3 | 3/44 (6.82) | 8/4327 (0.18) | <0.001 | 19/9345 (0.20) | <0.001 |
| MYH6 | 3/44 (6.82) | 20/4327 (0.46) | 0.002 | 50/9345 (0.53) | 0.002 |
| MYH7 | 2/44 (4.55) | 6/4327 (0.14) | 0.003 | 10/9345 (0.11) | 0.001 |
| NUP155 | 1/44 (2.27) | 1/4327 (0.02) | 0.02 | 3/9345 (0.03) | 0.019 |
| SGCD | 1/44 (2.27) | 55/4327 (1.27) | 0.438 | 143/9345 (1.52) | 0.497 |
| TNNT2 | 1/44 (2.27) | 0/4327 (0) | 0.01 | 0/9345 (0.00) | 0.005 |
| Total | 107.11 | 13.68 | 14.37 | ||
EAS indicates East Asian; MAF, minor allele frequency; SUNDS, sudden unexplained nocturnal death syndrome.
Nonsynonymous and splice site variants with MAF <0.01 in all SUNDS cases were compared with EAS in ExAC or gnomAD by χ2 tests using the SPSS 20.0. Continuity‐adjusted χ2 test or Fisher exact text are also chosen according to expected frequencies of the cells. A 2‐sided P<0.05 was considered significant.
P<0.05.
Figure 3Protein‐to‐protein interaction of the 33 genes responsible for SUNDS. We conducted a protein‐to‐protein interaction using STRING (https://string-db.org) and found that most of these proteins have a direct or indirect interaction with SCN5A. Line thickness indicates the strength of data support. SUNDS indicates sudden unexplained nocturnal death syndrome.
Figure 4Triple‐risk hypothesis of SUNDS. We propose that SUNDS occurs when 3 factors coincide: a vulnerable young person carrying susceptible variants; stressors caused by environmental or social factors; and finally a disturbance in action potential production and propagation in nocturnal sleep. The final pathway of SUNDS is commonly accepted as lethal ventricular arrhythmia. Cardiac structural changes may also be potential but unnecessary structure substrates for SUNDS. Whether the structural changes are a primary cause or a secondary change is still unknown. Certain associations between potential structure substrate, genetic risk factors, and impaired action potential production and propagation have yet to be demonstrated (dashed arrow). AP indicates action potential; REM, rapid eye movement; SUNDS, sudden unexplained nocturnal death syndrome.
Figure 5The multifactorial model of SUNDS. In this model, we set a supposed threshold for the multifactorial disease. The 2 major parts, namely, intrinsic genetic susceptibility and extrinsic risk burden, determine whether SUNDS occurs or not. People with different genetic background show different intrinsic genetic susceptibility to SUNDS. SUNDS indicates sudden unexplained nocturnal death syndrome.